A human trial of a hepatitis C treatment is shut down after one of the participants died.
The Scientist
Most Recent
Researchers consider the recent reappearance of West Nile virus in Texas and the efforts to control it.
Patent expirations of one HIV drugs will make the disease cheaper—but also more cumbersome—to treat.
At age 16, Alexandra Sourakov has her first scientific publication, on the foraging behavior of butterflies.
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
The first full computer model of a single-celled organism mimics the bacterium’s behaviors and paves the way to more complete disease models.
Rather than rely on plant-derived products, biotech companies are engineering bacteria and yeast to produce ingredients for fragrances.
Weakened viruses used in vaccines can swap genes and produce disease-causing strains.
Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
